Kaliber
Surgical Robotics and Real-Time Surgical Intelligence
PathAI
Discover how PathAI uses AI-powered pathology to accelerate drug development, enhance diagnostics, and improve patient outcomes. Explore AISight, its digital pathology platform.
About PathAI
Transforming Pathology with Artificial Intelligence
PathAI is at the forefront of a healthcare revolution, using AI to enhance diagnostic accuracy and improve patient outcomes. By collaborating with leading biopharma companies and pathology labs, PathAI integrates intelligent solutions into every stage of drug discovery, biomarker identification, and laboratory workflow optimization.
Supporting Better Health Outcomes
At its core, PathAI is committed to driving measurable improvements in how diseases are diagnosed and treated. Its technology enables faster, more consistent pathology assessments, providing critical support in precision medicine and clinical decision-making.
How PathAI Supports Biopharma
Enhancing Drug Development with AI
Pharmaceutical companies leverage PathAI to streamline clinical research and improve the reliability of histopathological evaluations. AI-driven insights support everything from early discovery to late-phase trials, accelerating timelines while maintaining high diagnostic standards.
Reliable Tools for Diagnostic Advancement
With extensive experience across oncology and immunology, PathAI delivers tools that help biopharma companies validate new diagnostics and companion tests. This enables more personalized and effective treatment strategies.
AISight: PathAI’s Digital Pathology Platform
Centralized Image and Case Management
AISight™ is PathAI’s cloud-native image management system, designed to unify the digital pathology experience. It acts as a single platform for managing digital slides, pathology cases, and AI-based analysis tools across laboratories and research environments.
Flexible for Research and Clinical Use
AISight enables multiple use cases, from routine diagnostic workflows to cutting-edge research projects. Its scalability and intelligent automation make it suitable for both individual labs and enterprise-level operations.
Real-World Impact and Collaborations
Partnering with Industry Leaders
PathAI’s impact spans a wide network of global healthcare leaders. It collaborates with top biopharma companies, research institutions, and digital health organizations. Recent partnerships with Quest Diagnostics, Google Cloud, and Hoag Health System underscore its growing influence in precision medicine.
A Contributor Network Built on Expertise
With a proprietary network of over 450 board-certified pathologists and more than 15 million annotations, PathAI’s AI algorithms are developed and validated through expert-reviewed data. This ensures high-quality performance in clinical and research applications.
A Platform for the Future of Pathology
Powering AI Across Top BioPharma Companies
Ninety percent of the world’s leading biopharma companies use PathAI’s tools to power digital pathology initiatives. Its proven solutions drive innovation in diagnostics, improve trial outcomes, and support regulatory success.
Leading the Shift to Digital Pathology
By promoting digital-first workflows, PathAI enables faster turnaround times, improved consistency in diagnosis, and more collaborative approaches to pathology. Its technology is at the core of the digital transformation happening across pathology labs globally.